Canton Strategic Holdings (CNTN) Profit After Tax (2021 - 2026)
Canton Strategic Holdings (CNTN) posted Profit After Tax of -$47.3 million for Q1 2026, down 60.94% on a QoQ basis from -$29.4 million in Q4 2025, and down 1762.66% year-over-year from $2.8 million in Q1 2025.
Canton Strategic Holdings (CNTN) Profit After Tax (2021 - 2026) Analysis & Trends
Canton Strategic Holdings' Profit After Tax history runs 6 years deep, the most recent figure standing at -$47.3 million for Q1 2026.
- Quarterly Profit After Tax fell 1762.66% year-over-year to -$47.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$80.7 million (down 546.61% YoY) and the FY2025 annual result came in at -$35.9 million, down 194.45% from the prior year.
- Profit After Tax was -$47.3 million for Q1 2026 at Canton Strategic Holdings, down from -$29.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$1.6 million in Q2 2022 and bottomed at -$47.3 million in Q1 2026.
- A 5-year average of -$6.7 million and a median of -$2.3 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2025 — Profit After Tax soared 44.63% — and 2026, when it sank 1762.66%.
- Canton Strategic Holdings' Profit After Tax stood at -$1.8 million in 2022, then tumbled by 40.04% to -$2.5 million in 2023, then sank by 54.44% to -$3.8 million in 2024, then slumped by 669.98% to -$29.4 million in 2025, then tumbled by 60.94% to -$47.3 million in 2026.
- Business Quant data shows CNTN's Profit After Tax at -$47.3 million in Q1 2026, -$29.4 million in Q4 2025, and -$2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | -47.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.34 Mn |
| Dec 31, 2025 | -29.42 Mn |
| Sep 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Mar 31, 2025 | -2.54 Mn |
| Dec 31, 2024 | -3.82 Mn |
| Sep 30, 2024 | -3.80 Mn |
| Jun 30, 2024 | -2.33 Mn |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Sep 30, 2023 | -1.82 Mn |
| Jun 30, 2023 | -2.34 Mn |
| Mar 31, 2023 | -2.69 Mn |
| Dec 31, 2022 | -1.77 Mn |
| Sep 30, 2022 | -2.13 Mn |
| Jun 30, 2022 | -1.64 Mn |
| Mar 31, 2022 | -2.94 Mn |
| Dec 31, 2021 | 2.45 Mn |
| Sep 30, 2021 | -853,436.00 |
| Jun 30, 2021 | -1.56 Mn |